Discovering
Yourself
In The
Test Tube
Learn from yesterday, live for today, hope for tomorrow. The important thing is not to stop questioning
-Albert Einstein-
Meet Prof. Gal Yadid
As the head of the Laboratory of Neuropsychopharmacology, I manage a research team of 8 PhD students, 3 graduate students, one postdoc student and a lab technician. Our lab is well-experienced with behavioral and pharmacological and genetic/epigenetic research-methods. I have a broad scientific background in both pharmacology and neuroscience, with specific training and expertise in key research areas including drug addiction, depression and PTSD. Over the last 7 years we have recruited personnel with expertise in state-of-the-art epigenetic and microbiome techniques, and thus established on-going collaborations with leading scientists in the field. I have successfully directed research projects in these and other significant collaborations, and produced several peer-reviewed publications from each project (see below). In summary, I have an established record of successful and productive research projects in areas of high significance in the neuropsychiatric field, and my expertise and experience have prepared me to lead other proposed collaborative projects.
Creating the future
PEP-1
Non addictive pain killer
Satus: Pre clinic study- last stage
Patent: Yes
Delta-opioid receptor agonistic peptides that attenuate cocaine craving and relief pain.
The 'opioad pandemic' is a real crisses.
In last decate the use of drugs, iiligel as well as missuse og ligel prescrepsion drugs, has become a major proplem all over the world and in US in praticcular.
PLAX-PAD
Drug delivery
Satus: Pre clinic study ended
Patent: Yes
Theranostic cell therapy for psychiatric disorder and drug delivery.
A drug delivery based on placenta stem cells that can cross the BBB and carry even big molecules.
Diagnosis and tretmant for PTSD
Satus: Pre clinic ended
Patent: Yes
A specific bacteria cluster of the gut microbiota Involvement in the progress of a unique PTSD treatment.
Psychodelic Ajents
New Treatments
Satus: Pre clinic study ended
Patent: Yes
Theranostic cell therapy for psychiatric disorder and drug delivery.
A drug delivery based on placenta stem cells that can cross the BBB and carry even big molecules.
miRNA- XXX
Biomarker for depression
Satus: Pre clinic ended
Patent: Pending
Discovery of Novel Biomarkers for Depression.
We live in a world the you can get almost anyting, but the levels of deppresion are higher then ever and still going.
with 19% of the world suffering from this issue its a fascinating and important.
SUD- Microbiome
New Treatments
Satus: Pre clinic study ended
Patent: Yes
Theranostic cell therapy for psychiatric disorder and drug delivery.
A drug delivery based on placenta stem cells that can cross the BBB and carry even big molecules.